|
|
Interleukin-6
Research News and Information
Definition of 'Interleukin-6'A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Common names: Interleukin-6; Interleukin 6; Plasmacytoma Growth Factor; Growth Factor, Plasmacytoma; B-Cell Differentiation Factor-2; B Cell Differentiation Factor 2; B-Cell Stimulatory Factor 2; B-Cell Stimulatory Factor-2; BSF-2; Differentiation Factor, B-Cell; Differentiation Factor, B Cell |
Monday, November 23, 2009
14 Dec 2009
OBJECTIVE: The aim of the study is to analyze whether chronic periodontitis (CP) influences serum tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and high-sensitivity C-reactive protein (hs-CRP) concentrations in renal transplant recipients ... Read more...
13 Nov 2009
Interleukin-6 (IL-6) may play a role in the pathogenesis of hepatocellular carcinoma (HCC). Recently, it was reported in mouse models that estrogen-mediated inhibition of IL-6 production explains the gender disparity in HCC. We conducted a ... Read more...
Diagnostic accuracy of neutrophil-derived circulating free DNA (cf-DNA/NETs) for septic arthritis.
30 Oct 2009
The release of "neutrophil extracellular traps" (NETs) has been identified as a novel immune response in innate immunity. NETs are composed of neutrophil-derived circulating free DNA (cf-DNA) and neutrophil cytoplasm-derived proteins such as ... Read more...
Latest indexed articles for 'Interleukin-6'
These are the very latest articles for this heading:
- The influence of chronic periodontitis on serum TNF-alpha, IL-6 and hs-CRP concentrations, and function of graft and survival of kidney transplant recipients.
14 Dec 2009 - Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences.
13 Nov 2009 - Diagnostic accuracy of neutrophil-derived circulating free DNA (cf-DNA/NETs) for septic arthritis.
30 Oct 2009 - Isoflurane preconditioning ameliorates endotoxin-induced acute lung injury and mortality in rats.
30 Oct 2009 - The effect of perioperative intravenous lidocaine on postoperative pain and immune function.
30 Oct 2009 - Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.
13 Oct 2009 - Cutting Edge: Importance of IL-6 and cooperation between innate and adaptive immune receptors in cellular vaccination with B lymphocytes.
13 Oct 2009 - Anti-inflammatory effects of caffeic acid phenethyl ester (CAPE), a nuclear factor-kappaB inhibitor, on Helicobacter pylori-induced gastritis in Mongolian gerbils.
13 Oct 2009 - Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.
13 Oct 2009 - In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha.
10 Oct 2009 - Correlation between anti-fibrotic effect of baicalin and serum cytokines in rat hepatic fibrosis.
5 Oct 2009 - Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes.
4 Oct 2009 - Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin.
29 Sep 2009 - Effect of biliary tract external drainage on cytokine expression and histomorphology of intestine, liver, and lung in rats with hemorrhagic shock.
29 Sep 2009 - No brain, no pain: does the injured brain stack up opioids?
29 Sep 2009 - Effect of acute inflammatory brain injury on accumulation of morphine and morphine 3- and 6-glucuronide in the human brain.
29 Sep 2009 - Sleep quality and immune mediators in asthmatic children.
29 Sep 2009 - Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
29 Sep 2009 - Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
29 Sep 2009 - Iron sequestration and anemia of inflammation.
29 Sep 2009
See a longer list of these articles.
Technical information about 'Interleukin-6'
Definition: A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS.
Registry Number: 0
Descriptor UI: D015850
Alternative terms: Interleukin-6; Interleukin 6; Plasmacytoma Growth Factor; Growth Factor, Plasmacytoma; B-Cell Differentiation Factor-2; B Cell Differentiation Factor 2; B-Cell Stimulatory Factor 2; B-Cell Stimulatory Factor-2; BSF-2; Differentiation Factor, B-Cell; Differentiation Factor, B Cell; Differentiation Factor-2, B-Cell; Differentiation Factor 2, B Cell; Hepatocyte-Stimulating Factor; Hepatocyte Stimulating Factor; Hybridoma Growth Factor; Growth Factor, Hybridoma; IFN-beta 2; IL-6; IL6; MGI-2; Myeloid Differentiation-Inducing Protein; Differentiation-Inducing Protein, Myeloid; Myeloid Differentiation Inducing Protein; B Cell Stimulatory Factor-2; B Cell Stimulatory Factor 2; B-Cell Differentiation Factor; B Cell Differentiation Factor;
Related Mesh Headings: Hybridomas; Plasmacytoma;
Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Tree Number: D12.644.276.374.465.506; D12.776.467.374.465.506; D23.529.374.465.506;
History Note: 90
Technical Notes: DF: IL 6 or IL6